Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.

Particle and Fibre Toxicology
Patrick L ApopaDaniel C Flynn

Abstract

Engineered iron nanoparticles are being explored for the development of biomedical applications and many other industry purposes. However, to date little is known concerning the precise mechanisms of translocation of iron nanoparticles into targeted tissues and organs from blood circulation, as well as the underlying implications of potential harmful health effects in human. The confocal microscopy imaging analysis demonstrates that exposure to engineered iron nanoparticles induces an increase in cell permeability in human microvascular endothelial cells. Our studies further reveal iron nanoparticles enhance the permeability through the production of reactive oxygen species (ROS) and the stabilization of microtubules. We also showed Akt/GSK-3beta signaling pathways are involved in iron nanoparticle-induced cell permeability. The inhibition of ROS demonstrate ROS play a major role in regulating Akt/GSK-3beta - mediated cell permeability upon iron nanoparticle exposure. These results provide new insights into the bioreactivity of engineered iron nanoparticles which can inform potential applications in medical imaging or drug delivery. Our results indicate that exposure to iron nanoparticles induces an increase in endothelial cell...Continue Reading

References

Jan 1, 1990·The American Review of Respiratory Disease·R G Holman, R V Maier
Sep 1, 1985·The Journal of Clinical Investigation·M J WelshR M Husted
Jul 3, 1999·Physiological Reviews·C C Michel, F E Curry
Aug 31, 1999·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·D O BatesB Williams
Mar 14, 2001·American Journal of Physiology. Cell Physiology·H Lum, K A Roebuck
Mar 19, 2002·International Journal of Pharmaceutics·Jasmine Davda, Vinod Labhasetwar
Apr 23, 2003·American Journal of Respiratory Cell and Molecular Biology·Irina PetracheAlexander D Verin
May 16, 2003·Vascular Pharmacology·Sarah Y Yuan
Dec 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anna A BirukovaAlexander D Verin
Mar 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S Moein MoghimiJ Clifford Murray
Mar 22, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Anna A BirukovaAlexander D Verin
Jun 14, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Anna A ShvedovaPaul Baron
Dec 24, 2005·Physiological Reviews·Dolly Mehta, Asrar B Malik
Feb 4, 2006·Science·Andre NelNing Li
Mar 3, 2006·BMC Cell Biology·Andrei I IvanovCharles A Parkos
Mar 28, 2006·Molecular Interventions·Bi-Sen DingVladimir R Muzykantov
Apr 26, 2006·Molecular Carcinogenesis·François Houle, Jacques Huot
Sep 19, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P CeppiG V Scagliotti
Nov 23, 2006·Advanced Drug Delivery Reviews·Claire CorotMarc Port
Dec 23, 2006·Environmental Health Perspectives·Maureen R Gwinn, Val Vallyathan
Feb 27, 2007·Biomaterials·Thomas R PisanicSungho Jin
Jul 28, 2007·Particle and Fibre Toxicology·Mary C BufordAndrij Holian
Sep 18, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Richard C MurdockSaber M Hussain
Mar 2, 2011·Physiology·Paul H AxelsenIan V J Murray

❮ Previous
Next ❯

Citations

Aug 13, 2011·Archives of Dermatological Research·Dimitrios PapakostasAnnika Vogt
Sep 23, 2010·Pharmaceutical Research·Michał Piotr Marszałł
Jul 19, 2011·ACS Nano·Tatsiana A RatnikovaPu Chun Ke
Mar 28, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Michaela Kendall, Stephen Holgate
Dec 25, 2010·Journal of Pharmacy & Bioallied Sciences·Vicky V ModyHardik R Mody
Apr 1, 2011·Therapeutic Delivery·Nicolas LaurenttOlivier Zelphati
Sep 13, 2013·BioMed Research International·Amruta MankeYon Rojanasakul
Jul 24, 2012·Therapeutic Delivery·Roland StoneFrank Alexis
Jun 6, 2013·Oxidative Medicine and Cellular Longevity·Ying-Ji LiArata Azuma
Jan 7, 2014·Biotechnology Advances·Jinxia LiYuliang Zhao
Nov 19, 2014·Nanomedicine·Chor Yong Tay, David Tai Leong
Oct 17, 2014·Nanomedicine·Magdiel Inggrid SetyawatiDavid T Leong
May 18, 2013·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·George R BailieRobert Levin
Oct 18, 2014·Nanotoxicology·Laetitia GonzalezMicheline Kirsch-Volders
Feb 2, 2016·Toxicology and Applied Pharmacology·Liming Wang, Chunying Chen
Apr 30, 2014·Expert Opinion on Drug Delivery·Monica LambertiMichele Caraglia
Jun 28, 2014·Advanced Drug Delivery Reviews·Hyun-Ho Greco SongSharon Gerecht
Mar 29, 2014·Journal of Food and Drug Analysis·Haohao WuY Martin Lo
Mar 20, 2012·Toxicology and Applied Pharmacology·Hua NaranmanduraNoriyuki Suzuki
Feb 4, 2016·Stem Cells International·Lisa AccomassoClaudia Giachino

❮ Previous
Next ❯

Methods Mentioned

BETA
dynamic light scattering
Dynamic
confocal microscopy
flow cytometry
transmission electron microscopy
transmission
electron microscopy

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.